Parkinson's disease (PD) is a neurodegenerative disorder affecting dopaminergic neurons in the substantia nigra, a part of the brain that controls movement. This progressive disease is characterized by motor and non-motor symptoms that can significantly impact a patient's quality of life.
While the exact cause of PD is unknown, it is believed to involve a combination of genetic and environmental factors. Pathologically, PD is characterized by the accumulation of alpha-synuclein, leading to the formation of Lewy bodies, and a reduction in dopamine production.
PD typically presents with resting tremor, bradykinesia, rigidity, and postural instability. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders may also be present. The disease usually begins unilaterally and progresses to bilateral involvement.
Diagnosis is primarily based on clinical features, with neuroimaging used to rule out other conditions. No definitive diagnostic test exists, and the disease is often misdiagnosed due to the variability in presentation and overlap with other parkinsonian syndromes.
Management focuses on symptom control and improving quality of life. Pharmacological treatment primarily involves dopamine replacement or modulation. Surgical interventions, such as deep brain stimulation, may be considered in patients with severe symptoms unresponsive to medication.
PD is a progressive disease with no cure. However, with appropriate management, many patients can maintain a good quality of life for many years. Prognosis is influenced by age of onset, disease severity, and presence of comorbidities.
Understanding the complexities of PD is crucial for healthcare professionals to provide optimal patient care. Through early recognition, accurate diagnosis, and individualized treatment strategies, healthcare professionals can help manage the symptoms and improve the quality of life of those affected by this challenging disease.
1.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC
5.
Hemihedral resection not necessary for neuroendocrine surgery after appendicitis
1.
Community Cancer Awareness Through Survivor Advocacy Networks
2.
Living Better With Advanced Cancer Through Supportive Care
3.
Oncology Communication Training for Difficult Conversations
4.
How AI is Transforming Diagnostics, Drug Discovery, and Personalized Oncology
5.
Different Types of Blood Dyscrasias
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
3.
Understanding the Importance of Early Cancer Detection
4.
Case-Based Learning: Oncology
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation